NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

預填充式注射器的全球市場 - 預測:2021年∼2026年

Global Prefilled Syringes Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023174
出版日期 內容資訊 英文 114 Pages
商品交期: 最快1-2個工作天內
價格
預填充式注射器的全球市場 - 預測:2021年∼2026年 Global Prefilled Syringes Market - Forecasts from 2021 to 2026
出版日期: 2021年07月07日內容資訊: 英文 114 Pages
簡介

全球預填充式注射器市場,從2019年的11億2,482萬6,000美元,到2026年達到24億665萬8,000美元,在預測期間內預計以11.48%的年複合成長率成長。罹患心臟病,糖尿病,自體免疫疾病等慢性疾病的患者數劇增,需要自己投藥的患者數劇增,也提高市場上預填充式注射器的需求。

本報告提供全球預填充式注射器市場相關調查分析,市場動態,各市場區隔的市場分析,競爭環境,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析
  • 產業價值鏈分析

第5章 預填充式注射器市場分析:各材料

  • 簡介
  • 玻璃
  • 塑膠

第6章 預填充式注射器市場分析:各用途

  • 簡介
  • 疫苗
  • 藥物輸送

第7章 預填充式注射器市場分析:各終端用戶

  • 簡介
  • 醫院、診所
  • 門診病人診療中心
  • 居家醫療

第8章 預填充式注射器市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 中東、非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 印尼
    • 台灣
    • 泰國
    • 其他

第9章 競爭資訊

  • 競爭基準與分析
  • 最近的投資和交易
  • 主要企業的策略

第10章 企業簡介

  • Chemi SPA
  • Catalent, Inc.
  • Becton, Dickinson and Company
  • Nipro Corporation
  • Taisei Kako Co. Ltd.
  • MEDEFIL, INC.
  • Alfasigma S.p.A
  • Aquabiliti
  • Schott AG
  • Vetter Pharma International GmbH
目錄
Product Code: KSI061611621

The global prefilled syringes market is projected to witness growth at a CAGR of 11.48% during the forecast period to reach US$2,406.658 million by 2026, increasing from US$1,124.826 million in 2019. Prefilled syringes refer to the disposable syringe that is already loaded with the unit dose of the substance to be injected to which a needle has already been fixed by the manufacturer. The syringes are designed in such a way that it administers the accurate amount of dosage, thus, reducing the wastage of the medication. The rising preference for the prefilled syringes over the conventional syringe-vial combination because of the advantages offered by prefilled syringes such as increased patient safety and convenience, accuracy, etc. is the key factor driving the growth of the industry. In addition, the growth is attributed to the increasing prevalence of chronic diseases, reduced medication errors, and better use of controlled drugs such as narcotics using prefilled syringes.

The rapidly increasing number of patients suffering from chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications will bolster the demand for prefilled syringes in the market. According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the United States. To help the patients self-administer medications, for these chronic conditions the requirement for prefilled syringes has expanded in the market, which will drive the market growth of the prefilled syringes market. Furthermore, the supportive government regulations (especially needlestick legislation) will further boost the market growth. According to a report published by Geneva Association, in the last two decades, the total aggregate global expenditure on healthcare in GDP has increased from 8% to almost 10%, which is driven by the exorbitant cost of medical treatment, growing treatment options, and increasing customer demands. The increasing spending on medical expenditure by both developed and developing countries will augment the market growth of the global prefilled syringes market. Also, prefilled syringes are largely used for vaccination of the population against diseases such as polio, coronavirus, hypothesis, etc. will contribute to the market growth during the forecast period.

By material, the glass segment is expected to hold a dominant market share owing to the benefits of glass syringes over plastic syringes such as the prevention of oxygen and water vapor from interacting with drug compounds, and compatibility with different filling machines. By end-user, the home care settings segment is estimated to grow at the highest CAGR as the increasing number of patients inflicted with chronic diseases, worldwide use prefilled syringes as a part of their treatment. Geographically, Europe is projected to be the largest revenue-generating segment owing to the prevalence of chronic diseases, technological advancements, and geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices. North America is expected to witness the fastest growth rate during the forecast period due to the rapid adoption of prefilled syringes in the region.

Growth Factors.

  • Increasing disease population.

The increasing incidence and prevalence of chronic and lifestyle diseases globally is a major key driver of the prefilled syringes market. Due to the rising prevalence of diseases, the requirement for self-injection devices is further increasing in the market as they have convenience and safety associated with their use. According to the International Diabetes Federation, 1 in 5 people who are above 65 years old has diabetes. The World Health Organization, 2018, recorded the total number of cancer patients, nationwide to be around 18 million. The rise in the number of patients will increase the demand and adoption of prefilled syringes in the long run.

Restraints.

  • Availability of cheap alternatives.

The availability of cheaper alternatives to the prefilled syringes and focus on the development of alternative drug delivery methods might restrain the market during the given time frame. The prefilled syringes are expensive as they have a challenging manufacturing procedure due to which the patients might often resort to cheaper alternatives for drug delivery such as needle-free injectors, etc. which hamper the market growth. Also, a large number of needle stick injuries are associated with the use of bare prefilled syringes as patients are not aware of using the prefilled syringes on their own without any medical assistance, which may result in hurting them.

Impact of COVID-19.

The Covid-19 pandemic positively impacted the global prefilled syringes market as due to the nationwide lockdown restrictions, the patients who required regular injections preferred to use prefilled syringes on their own as opposed to visiting the hospitals or clinics. This considerably increased the demand for the prefilled syringes in the market. Furthermore, due to the novel coronavirus outbreak, the number of people who suffered from chronic illnesses exponentially increased, subsequently accelerating the demand for prefilled syringes, across the globe.

Competitive Insights.

The market leaders for the global prefilled syringes market include Chemi SPA, Catalent, Inc., Becton, Dickinson and Company, Nipro Corporation, Taisei Kako Co. Ltd., MEDEFIL, INC., Alfasigma S.p.A, Aquabiliti, Schott AG, and Vetter Pharma International GmbH. The key players in the market implement growth strategies to gain a competitive advantage over their competitors and to remain the market leaders. For Instance, in February 2021, Catalent, Inc., a global provider of delivery technologies, and drug manufacturing has acquired Delphi Genetics, a Belgian plasmid DNA cell and gene therapy CDMO and has also launched pDNA development and manufacturing services at its Rockville, Maryland facility to expand plasmid DNA services.

Market Segmentation:

  • By Material
  • Glass
  • Plastic
  • By Application
  • Vaccination
  • Drug Delivery
  • By End-Users
  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Home Care Settings
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Prefilled Syringes Market Analysis, By Material

  • 5.1. Introduction
  • 5.2. Glass
  • 5.3. Plastic

6. Prefilled Syringes Market Analysis, By Application

  • 6.1. Introduction
  • 6.2. Vaccination
  • 6.3. Drug Delivery

7. Prefilled Syringes Market Analysis, By End-User

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers
  • 7.4. Home Care Settings

8. Prefilled Syringes Market Analysis, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. Israel
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Indonesia
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Others

9. Competitive Intelligence

  • 8.1. Competitive Benchmarking and Analysis
  • 8.2. Recent Investment and Deals
  • 8.3. Strategies of Key Players

10. Company Profiles

  • 10.1. Chemi SPA
  • 10.2. Catalent, Inc.
  • 10.3. Becton, Dickinson and Company
  • 10.4. Nipro Corporation
  • 10.5. Taisei Kako Co. Ltd.
  • 10.6. MEDEFIL, INC.
  • 10.7. Alfasigma S.p.A
  • 10.8. Aquabiliti
  • 10.9. Schott AG
  • 10.10. Vetter Pharma International GmbH